SHANGHAI (Reuters) - Eli Lilly (NYSE:) said on Tuesday its diabetes drug tirzepatide has received approval from Chinese regulators, setting up intensifying competition...
Apple’s payment business is heavily underappreciated among investors, said Evercore ISI analysts in a note, citing positive feedback from their conversations with an expert...